|
HY-P2026-5mg
|
MedChemexpress LLC
|
A 71915 [CAS 132956-87-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-12583-1mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-10mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-5mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-50mg
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2]
|
|
Cancer-programmed cell death
|
|
|
HY-12583-1mL
|
MedChemexpress LLC
|
A-366 [CAS 1527503-11-2] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P1096-1mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1096-10mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P1096-5mg
|
MedChemexpress LLC
|
A71623 [CAS 130408-77-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-120833-1mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-10mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-25mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-120833-5mg
|
MedChemexpress LLC
|
Ac-Ile-Glu-Thr-Asp-pNA [CAS 219138-21-3]
|
|
|
|
|
HY-124071-1mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-124071-10mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-124071-100mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-124071-25mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-124071-5mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-124071-50mg
|
MedChemexpress LLC
|
ACT-389949 [CAS 1258417-54-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-113952-10mg
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-113952-100mg
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-113952-25mg
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-113952-5mg
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-113952-50mg
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-113952-1mL
|
MedChemexpress LLC
|
Actinonin [CAS 13434-13-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
